19-15238785-C-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001379291.1(BRD4):c.3978G>T(p.Glu1326Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00082 in 1,584,550 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001379291.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BRD4 | NM_001379291.1 | c.3978G>T | p.Glu1326Asp | missense_variant | 19/20 | ENST00000679869.1 | NP_001366220.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BRD4 | ENST00000679869.1 | c.3978G>T | p.Glu1326Asp | missense_variant | 19/20 | NM_001379291.1 | ENSP00000506350.1 | |||
BRD4 | ENST00000263377.6 | c.3978G>T | p.Glu1326Asp | missense_variant | 19/20 | 1 | ENSP00000263377.1 |
Frequencies
GnomAD3 genomes AF: 0.00101 AC: 154AN: 152266Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.00359 AC: 831AN: 231328Hom.: 11 AF XY: 0.00288 AC XY: 365AN XY: 126724
GnomAD4 exome AF: 0.000800 AC: 1146AN: 1432168Hom.: 12 Cov.: 32 AF XY: 0.000709 AC XY: 502AN XY: 707918
GnomAD4 genome AF: 0.00101 AC: 154AN: 152382Hom.: 2 Cov.: 32 AF XY: 0.00121 AC XY: 90AN XY: 74520
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2024 | - - |
BRD4-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 30, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at